期刊文献+

两种方法定量分析肝硬化患者肠道菌群改变的比较 被引量:3

Comparison of two methods applied in the quantitative analysis of gut flora alteration in patients with liver cirrhosis
下载PDF
导出
摘要 目的观察肝硬化患者肠道菌群改变,探讨传统培养法与实时定量PCR检测结果的一致性。方法纳入73名肝硬化患者及55名健康人,对其粪便细菌进行传统培养及定量PCR,比较两种方法检测结果的一致性。结果细菌培养结果显示,与正常对照组比较,肝硬化患者肠杆菌、肠球菌、葡萄球菌、酵母菌数量显著增加(P分别为0.004、0.002、0.044、0.026),拟杆菌、乳酸杆菌、双歧杆菌、梭菌数量显著降低(P分别为0.029、0.046、0.045、0.045)。定量PCR结果显示,肝硬化组肠杆菌、肠球菌数量显著增高(P分别<0.01、0.012),乳酸杆菌、双歧杆菌、拟杆菌及梭菌数量显著降低(P均为<0.01)。结论肝硬化患者存在不同程度肠道菌群失衡,可能影响病情发展。传统细菌培养与荧光定量PCR的结果具有良好的一致性,但定量PCR更精确、灵敏、省时、省力。 Aims The objective of our research is to explore the consistency between traditional culture and real-time quantitative PCR(qPCR) through testing fecal microbiota in patients with liver cirrhosis. Methods 73 patients with liver cirrhosis and 55 healthy controls were enrolled. Their fecal bacteria were detected by traditional culture and qPCR, and the results from two different methods were compared. Results To compare with healthy controls, culture results showed that the lever of Escherichia coli, Enterococcus, staphylococcus and yeast was significantly enriched(P = 0.004, 0.002, 0.044, 0.026, respectively), Bacteroides, LactobaciUus, Bifidobacterium and Clostridium were significantly reduced in patient group(P = 0.029, 0.046, 0.045, 0.045, respectively), qPCR results suggested that the amount of Escherichia coli and Enterococcus were statistically increased(P 〈 0.01, 0.012, respectively), Lactobacillus, Bifidobacterium, Bacteroides and Clostridium were statistically decreased(all P 〈 0.01). Conclusion Fecal microbial communities are imbalanced in cirrhotic pa- tients compared with healthy individuals, which may affect the prognosis. The results of traditional culture and qPCR are consistent, but the latter with the more accurate and sensitive, time saving, energy saving.
出处 《现代消化及介入诊疗》 2012年第1期5-8,共4页 Modern Interventional Diagnosis and Treatment in Gastroenterology
基金 广东省自然科学基金(9151051501000048)
关键词 肠道菌群 肝硬化 传统培养 实时定量PCR Gut flora Liver cirrhosis Traditional culture Real-time quantitative PCR
  • 相关文献

参考文献19

  • 1Garcia-Tsao G,Wiest R.Gut microflora in the pathogenesis of the complications of cirrhosis.Best Pract Res Clin Gastroenterol,2004,18:353-372.
  • 2范东旭,杨婷,房淑清,罗维,王跃生.肝硬化病人血清内毒素水平与肠道菌群的关系[J].黑龙江医药科学,2005,28(1):12-14. 被引量:6
  • 3陈穗,陈桂明,严虹,潘令嘉.肝炎后肝硬化患者肠道菌群变化初步分析[J].中华消化杂志,1995,15(2):75-77. 被引量:49
  • 4Matsuki T,Watanabe K,Fujimoto J,et al.Development of16S rRNA-Gene-Targeted group-specific primers for the detection and identification of predominant bac.
  • 5Rinttil,T,Kassinen A,Malinen E,et al.Development of an exten-sive set of16S rDNA targeted primers for quantification of pathogenic and indigenous bacteri.
  • 6Eckburg PB,Bik EM,Bernstein CN,et al.Diversity of the human intestinal microbial flora.Science,2005,308(5728):1635-1638.
  • 7McKenna P,Hoffmann C,Minkah N,et al.The macaque gut micro-biome in health,lentiviral infection,and chronic enterocolitis.PLoS Pathog,2008,4(2):e20.
  • 8Dethlefsen L,Huse S,Sogin ML,et al.The pervasive effects of an antibiotic on the human gut microbiota,as revealed by deep16S rRNA sequencing.PLoS Biol,20.
  • 9Turnbaugh PJ,Hamady M,Yatsunenko T,et al.A core gut micro-biome in obese and lean twins.Nature,2009,457(7228):480-484.
  • 10Bajzer M,Seeley RJ.Physiology:obesity and gut flora.Nature,2006,444(7122):1009-1010.

二级参考文献10

  • 1刘丽娜,傅永潜.肝硬化患者肠道菌群状态之初步探讨[J].中华流行病学杂志,1989,10(5):287-290. 被引量:3
  • 2杨玉秀 田建国.门脉高压症[M].北京:北京科学技术出版社,1999.91-98.
  • 3Keraan M, Mcyers OL, Engelbrecht GHC, et al. Increased immunoglobul in levels following portacaval shunt in normal rat[J]. Gut, 1974,15(2) :468
  • 4Bourgoingnie JJ, Valle GA. Endotoxin and renal disfunction in liver disease, In : Baltimore Williams. Wilkins. The kidney in liver disease[J]. Califonia: Appleton & Lang, 1988,486
  • 5陈穗,中国微生物学杂志,1989年,1卷,48页
  • 6陈聪敏,厌氧菌及其感染,1989年
  • 7康白,微生态学,1988年
  • 8熊德鑫,中国人兽共患病杂志,1987年,3卷,53页
  • 9康白,正常菌群与健康,1985年
  • 10赵海英,王惠吉,吕治,许淑珍.肝硬化患者肠道菌群的研究[J].中华消化杂志,2003,23(7):407-409. 被引量:56

共引文献52

同被引文献24

  • 1金峰,张捷,张志坚,余英豪,李鸣,袁芳,薛建设.双歧杆菌制剂对大鼠肝硬化模型的影响[J].中国微生态学杂志,2004,16(5):269-271. 被引量:2
  • 2黄自平 粱扩寰.肝病时的内毒素血症[A].粱扩寰 主编.肝脏病学 第1版[C].北京,人民卫生出版社,1995.397—411.
  • 3Madrid A M,Brahm J,Antezana C,et al.Small bowel motility inprimary biliary cirrhosis[J].Am J Gastroenterol,1998,93(12):2436-2440.
  • 4Kim J W,Jeon W K,Yun J W,et al.Intestinal permeability in pa-tients with viral and alcoholic liver disease[J].Korean J Gastroen-terol,2004,43(2):104-111.
  • 5Guarner C,Soriano G.Bacterial translocation and its consequencesin patients with cirrhosis[J].Eur J Gastroenterol Hepatol,2005,17(1):27-31.
  • 6Vlachogiannakos J,Daikos G,Thalheimer U,et al.Is bacterial DNAa better marker than endotoxin of bacterial translocation in decom-pensated cirrhosis[J].Hepatology,2011,53(6):2140-2141.
  • 7Xing HC, Li LJ, Xu KJ. Protective role of supplement with foreign Bifidobaeterium and Laetobaeillus in experimental hepatic isehemia- reperfusion injury[ J]. J Gastmenteml Hepatol,2006 ,21:647456.
  • 8Meng QH, Yu HW, Li J, Inadequate nutritional in take and protein- energy malnutrition involved in acute and chronic viral hepatitis Chi- nese patients especially in cirrhosis atients [ J ]. Hepatogastroenterol- ogy,2010,57( 101 ) :845-851.
  • 9Marcellin P, Gane E, Buti M. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B : a 5-year open-label follow-up study [ J ]. Lancet, 2012,11 : 1-8.
  • 10Othman M, Aguero Pt ,Lin HC. Alterations in intestinal microbial flo- ra and human disease [ J ]. Curr Opin Gastroenterol, 2008,24 : 11 - 16.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部